Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 133

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 133
---
1) | For purposes of determining any liability under the Securities Act of 1933, the information omitted from                                   
 the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed 
 by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration    
 statement as of the time it was declared effective.                                                                                        |

| (2) | For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment                          
 that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and 
 the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.                            |

| II-4 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Cardiff, Wales, on
this 29th day of April, 2025.

| BIODEXA PHARMACEUTICALS PLC |                         |
| By:                         | /s/ Stephen Stamp       |
|                             | Stephen Stamp           |
|                             | Chief Executive Officer |

Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement on Form F-1 has been signed by the following persons in the capacities and on the date indicated.

| Name and Signature    
 /s/ Stephen Stamp     |     | Title(s)                                                                                  
 Chief Executive Officer, Director,                                                        |     | Date           
 April 29, 2025 |
|:----------------------|:----|:------------------------------------------------------------------------------------------|:----|:---------------|
| Stephen Stamp         |     | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |                |
| *                     |     | Non-Executive Chairman of the Board                                                       |     | April 29, 2025 |
| Stephen Parker        |     |                                                                                           |     |                |
| *                     |     | Senior Independent Non-Executive Director                                                 |     | April 29, 2025 |
| Simon Turton, Ph.D